中华地区独家报道
预告
回顾
房颤网  先心病网
高血压网 血管病变网
冠心病网 血脂网
阿司匹林网 血糖血管网
血栓网 心律失常网
心衰网 糖尿病网
瓣膜网 代谢综合征网
心外科 心电生理 瓣膜网 代谢综合征网
 
1.体表心电图
   urface ECG
1.ST段抬高性心肌梗塞的定位和罪犯血管的诊断
  Algorithm for diagnosis the culprit coronary artery and the location of occlusion in STEMI
  Drs. A Bayés de Luna – M. Fiol
2.急性冠脉综合症的心电图不同表现类型
  Different ECG patterns at presentation in ACS.
  Drs. D Goldwasser - A Bayés de Luna –? M Santaló - K. Nikus
3.ST段抬高的鉴别诊断
  Differential diagnosis of ST segment elevation patterns
  Dr. Y Birnbaum
4.延迟增强核磁共振心肌灌注扫描(CMR)基础上心脏各壁的命名新视点,与Q波心梗的新分类
  New terminology of the walls of the heart and new classification of Q-wave MI based on the standards of CMR
  Drs. A Bayés de Luna, G Wagner, W Zareba
5.肌坏死的定量分析:延迟增强核磁共振心肌灌注扫描(CMR)时代的Selvester评分
  Quantification of myocardial necrotic mass: The role of Selvester score in the era of CMR
  Dr. G. Wagner
6.如何评价ST段抬高性急性冠脉综合症
  How we can evaluate the degree of ischemia in STE-ACS?
  Dr. Y Birnbaum, S Sclarowsky
7.那一种是冠脉痉挛的心电图改变?
  Which are the ECG changes in coronary spasm?
  Drs. A Bayés de Luna, S Stern
8.左束支阻滞患者急性冠脉综合症和慢性心梗的鉴别诊断。
  Identification of ACS or chronic MI in patients with LBBB
  Drs. A Bayés-Genis, A. Pérez Riera,? A Bayés de Luna
9.起搏器植入患者急性冠脉综合症和慢性心梗的鉴别诊断。
  Identification of ACS or chronic MI in patients with pacemakers.
  Drs. D Goldwasser, A Bayés de Luna, R. Baranowski
10.ST段抬高性心梗ST段变化的意义
   Significance of ST segment resolution patterns in STEMI
   Dr. Ben Scirica

II.Holter监测
   Holter Monitoring

A.ST段抬高性心梗:分析ST段偏移程度、抬高模式以及变化模式的复杂程度
  STEMI: Risk stratification utilizing extent of ST deviation, complexity of pattern of elevation, and complexity of pattern
  of resolution
  Dr. Peter Stone
B.缺血基础上的非ST段抬高性心梗危险分层
  Non-STEMI risk stratification based on ischemia
  Dr.Ben Scirica
C.Holter监测评价非ST段抬高性心梗的药物干预效果
  Significance of pharmacologic intervention in Non-STEMI as assessed by Holter monitoring
  Dr.Ben Scirica
D.急性冠脉综合症患者心律失常早期风险的评价
  Assessment of early risk of arrhythmia risk in ACS
  Drs.Scirica, Hedgepeth
E.新技术评价的P-QRS-T波形形态变化进行危险分层
  Risk stratification based on novel technique analyzing morphologic variability of P-QRS-T waves
  Drs.Scirica and Zeeshan Syed
F.心率震荡和减速能力
  Heart rate turbulence and deceleration capacity
  Dr. Georg Schmitd

II.T波电交替
    wave Alternans

A. Holter和运动试验进行T波电交替的时域分析
T-wave alternans using Time Domain analyses from the Holter and Exercise Test
Dr. Richard Verrier
B. 频域分析T波电交替
T-wave alternans using the Spectral method
Dr. Thomas Kleigenhaben
C. 应用T波电交替进行心脏猝死的危险分层
Risk Stratification for Sudden Cardiac Death using T-wave alternans

IV.缺血性心脏病的治疗
    Management of IHD

A. 稳定性冠心病
Stable CAD
    药物治疗概述
    Pharmacological management: An overview –
    D Cokkinos (Greece)
    心绞痛新的药物治疗方法—心率控制和代谢调整
    New pharmacologic approaches to the management of angina pectoris – Heart rate control and metabolic modulation
    心率控制– Ibravadine (Procoralan) 的机制和指正
    Heart rate control – Ibravadine (Procoralan) Mechanisms and indicatons– ?J Camm (UK)
    Procoralan 的实际应用
    Practical aspects of the use of Procoralan –(Webcast interview with J Camm et al)
    代谢调整– Trimetazidine (Vastarel)
    Metabolic modulation – Trimetazidine (Vastarel) – M Marzilli (Italy)
    缺血性心肌病患者的Trimetazidine治疗
    Trimetazidine in patients with ischemic cardiomyopathy
    JC Kaski (UK) – V Bertomeu (Spain)
    心绞痛合并2型糖尿病的代谢调整治疗
    Metabolic modulation for treatment of angina in patients with type 2 diabetes –?G Rosano (Italy)
    心绞痛的激素治疗
    Hormone therapy in angina pectoris – G Rosano (Italy)
    Ranolazine – P Stone (USA)
    Nicorandil – H Dargie (UK)
    PCI治疗:裸支架vs. 药物涂层支架
    Percutaneous Coronary Intervention: BMS vs DES –J Popma (USA); E Camenzind (Switzerland); G Stone (USA)
    稳定性冠心病的PCI治疗:COURAGE试验
    PCI for Patients with Stable CAD: The COURAGE Trial –  B Boden (USA)
    心脏停跳与不停跳冠状动脉搭桥术的对比分析<
    On and Off- pumpsurgery for management of CAD – M Jahangiri (UK)
    变异性心绞痛的治疗
    Variant angina - management– R Arroyo-Espliguero (Spain) and JC Kaski (UK))
    心脏X综合症的治疗
    Cardiac Syndrome X – management – G Lanza (Rome)
    心绞痛合并2型糖尿病的治疗
    Management of patients with angina and type 2 diabetes – D Tziakas (Greece)
    心梗重构后的标记物
    Markers of post MI remodelling - D Tziakas (Greece)
B. 二级预防
   Secondary prevention
    抗血小板治疗的最新进展
    The role of antiplatelet agents–What’s New  M Cattaneo (Italy)
    Triflusal:冠心病二级预防以及其他心血管疾病的指征
    Triflusal : Secondary prevention of CAD and other indications in cardiovascular disease– J Garcia –Rafanell (Spain)
    (WEBCAST)
    ACEI和ARB治疗作用概述
    The role of ACE inhibitors and ARBs – An overview - JC Kaski (UK) and D Fernandez Berges (Spain)
    ACEI——热点话题
    ACE Inhibitors – Hot topics – M Bertrand (France)
    他汀类药物的角色——新方法
    The role of statins – New approaches –K Ray (UK)
    omega 3脂肪酸的角色
    The role of omega 3 fatty acids – N Al-Saady (UK)
    急性冠脉综合症后的二级预防概述
    Secondary prevention following an ACS: An overview
    K Ray (UK)
C. 急性冠脉综合症
   Acute Coronary Syndromes (ACS)
    ST段抬高性心肌梗塞治疗概述
    Management of patients with STEMI: An overview
    J Adgey (UK)
    欧洲心脏病协会指南
点击注册 查看更多

心血管网 版权所有 365heart All Rights Reserved.
电话:总机010-51955830 客服1016 编辑1008 外联1005 技术1011
E-mail:365heart@vip.163.com 
京ICP证041347号 京卫网审字[2005]第5号